News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Stuart McElroy, PhD, also joins as director of biosciences.
“Joining BioAscent provides a really exciting opportunity to introduce a unique team of experienced drug discovery specialists to the market place. I genuinely believe that the expertise, experience and infrastructure – including on-site access to a large, diverse IP-free compound library - make us one of the premier drug discovery groups to be found anywhere in the world,” he told us.
“I’m looking forward to growing the business and working with new and existing BioAscent clients to realise their drug development goals throughout the discovery process, from initial development of assays to preclinical candidates.”